Based on the Wall Street analyst consensus for 193 of DE:NBTK’s holdings.
DE:NBTK 12 Month Forecast
Average Price Target
$88.36▲(0.00% Upside)
Based on Wall Street analyst 12-month price targets for 193 of Invesco NASDAQ Biotech UCITS ETF’s holdings in the last 3 months. The average price target is $88.36 with a high forecast of $113.74 and a low forecast of $65.57. The average price target represents a ― change from the last price of ―.
What is DE:NBTK’s average 12-month price target, according to analysts?
Based on Wall Street analyst price targets for 193 of DE:NBTK’s holdings, Invesco NASDAQ Biotech UCITS ETF’s 12-month average price target is $88.36.
Is DE:NBTK a Buy, Sell or Hold?
Invesco NASDAQ Biotech UCITS ETF has a consensus rating of Moderate Buy, based on the analyst consensus for 193 of DE:NBTK’s holdings: 163 rated Buy, 29 rated Hold and 1 rated Sell.
What is Invesco NASDAQ Biotech UCITS ETF’s price target?
The average price target for Invesco NASDAQ Biotech UCITS ETF is $88.36, based on Wall Street analyst 12-month price targets for 193 of DE:NBTK’s holdings, issued in the past 3 months. The highest price target is $113.74 and the lowest is $65.57.
How many holdings does DE:NBTK have?
DE:NBTK holds 268 assets.
How can I buy shares of DE:NBTK?
You can buy shares of DE:NBTK through a brokerage account. Compare brokers on our Best Online Brokers page.